Most Recent Articles about AMPH
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4305274-amphastar-pharmaceuticals-inc-amph-management-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 10, 2019 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2019 Earnings Conference Call November 7, 2019 17:00 ET Company Participants Jason Shandell - President Bill Peters - CFO Conference Call Participants
Amphastar Pharmaceuticals Inc (AMPH) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/11/08/amphastar-pharmaceuticals-inc-amph-q3-2019-earning.aspx?source=iedfolrf0000001 Nov 08, 2019 - AMPH earnings call for the period ending September 30, 2019.
Amphastar Pharmaceuticals Inc (AMPH) CEO & Chief Scientific Officer Jack Y. Zhang Sold $6. ... http://www.gurufocus.com/news/945851/amphastar-pharmaceuticals-inc-amph-ceo--chief-scientific-officer-jack-y-zhang-sold-62-million-of-shares Sep 12, 2019 - Amphastar Pharmaceuticals Inc (AMPH) CEO & Chief Scientific Officer Jack Y. Zhang Sold $6.2 million of Shares, Stocks: AMPH, release date:Sep 12, 2019

Related Companies

Name Exchange Price Mkt Cap
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
CARA Cara Therapeutics, Inc. NASDAQ $21.19 $832.56M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
ASMB Assembly Biosciences, Inc. NASDAQ $34.41 $875.61M
Sector: Health Care > Industry: Major Pharmaceuticals